Figure 2From: Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways Reduction in LPS-induced lung inflammation by RGDS. Mice were administered RGDS (5 mg/kg, i.p.) once 1 h before or 2 h after LPS and were sacrificed 24 h post-LPS. Lung sections were H&E stained, as described in Methods. Representative staining from 5 mice per group are shown.Back to article page